Esther Alonso Gil

Esther Gil is an Associate Director in Global Regulatory Affairs at Eli Lilly, specializing in strategic regulatory leadership and clinical development. With a background in regulatory affairs and pharmacovigilance, Esther collaborates with biotech companies in early clinical phases to facilitate drug development. Holding multiple Master's degrees in Pharmaceutical Industry, Data Analysis, Business Intelligence, and Project Management, Esther combines scientific knowledge with strategic insight. Previously, Esther has held senior roles at ICON plc and IQVIA, managing regulatory submissions and supporting various clinical trials. Esther's passion lies in transforming innovative therapies into real solutions for patients, leveraging expertise at the intersection of science, data, and regulatory strategy.